1 recruiting, 1 unknown, 1 withdrawn. 1 Not applicable, 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Recruiting 1 |
| Phase 1 | 1 | Withdrawn 1 |
| Phase 4 | 1 | Unknown 1 |
Follow IgE-Mediated Hypersensitivity: new trials by email Literature Review of IgE-Mediated Hypersensitivity trials Research Report on IgE-Mediated Hypersensitivity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1 Study of Cizutamig in IgE Mediated Diseases Cizutamig - IgE-Mediated Hypersensitivity, IgE Mediated Food Allergy | Phase 1 | Withdrawn | Candid Therapeutics | 2026-04-01 | 2026-07-22 | |
| Birth Cohort: Development of IgE Autoantibodies in Newborns With (High Risk of) Atopic Dermatitis Development of atopic dermatitis with/without IgE autoantibodies - Atopic Dermatitis (AD), Autoantibody | Not applicable | Recruiting | Universitair Ziekenhuis Brussel | 500 | 2023-10-01 | 2026-01-05 |
| Safety of Ertapenem in Beta-lactam Allergic Patients. ertapenem - IgE-Mediated Hypersensitivity, Allergy | Phase 4 | Unknown | Catholic University of the Sacred Heart | 30 | 2011-01-01 | 2011-01-05 |
Hypersensitivity, Immediate (3) · Dermatitis, Atopic (2) · Asthma (1) · Egg Hypersensitivity (1) · Food Hypersensitivity (1) · Hypersensitivity (1) · Milk Hypersensitivity (1) · Nut Hypersensitivity (1) · Peanut Hypersensitivity (1) · Rhinitis, Allergic (1) · Rhinosinusitis (1) · Urticaria (1) · Wheat Hypersensitivity (1)
Immune System Diseases (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Dermatitis (2) · Genetic Diseases, Inborn (2) · Hypersensitivity (2) · Skin Diseases (2) · Skin Diseases, Eczematous (2) · Skin Diseases, Genetic (2) · Skin and Connective Tissue Diseases (2) · Bronchial Diseases (1) · Infections (1) · Lung Diseases (1) · Lung Diseases, Obstructive (1) · Nose Diseases (1) · Nut and Peanut Hypersensitivity (1)
Ertapenem (1)
Candid Therapeutics (1) · Catholic University of the Sacred Heart (1) · Universitair Ziekenhuis Brussel (1)
Australia (1) · Belgium (1) · Italy (1)
Domenico Schiavino, MD (1) · Inge Kortekaas Krohn, PhD (1) · Jan Gutermuth, MD PhD (1)